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Abstract
Background: During an influenza epidemic prompt diagnosis of influenza is important. This diagnosis however is
still essentially based on the interpretation of symptoms and signs by general practitioners. No single symptom is
specific enough to be useful in differentiating influenza from other respiratory infections. Our objective is to
formulate prediction rules for the diagnosis of influenza with the best diagnostic performance, combining
symptoms, signs and context among patients with influenza-like illness.
Methods: During five consecutive winter periods (2002-2007) 138 sentinel general practitioners sampled (naso-
and oropharyngeal swabs) 4597 patients with an influenza-like illness (ILI) and registered their symptoms and signs,
general characteristics and contextual information. The samples were analysed by a DirectigenFlu-A&B and RT-PCR
tests. 4584 records were useful for further analysis.
Starting from the most relevant variables in a Generalized Estimating Equations (GEE) model, we calculated the
area under the Receiver Operating Characteristic curve (ROC AUC), sensitivity, specificity and likelihood ratios for
positive (LR+) and negative test results (LR-) of single and combined signs, symptoms and context taking into
account pre-test and post-test odds.
Results: In total 52.6% (2409/4584) of the samples were positive for influenza virus: 64% (2066/3212) during and
25% (343/1372) pre/post an influenza epidemic. During and pre/post an influenza epidemic the LR+ of ‘previous
flu-like contacts’, ‘coughing’, ‘expectoration on the first day of illness’ and ‘body temperature above 37.8°C’ is
3.35 (95%CI 2.67-4.03) and 1.34 (95%CI 0.97-1.72), respectively. During and pre/post an influenza epidemic the
LR- of ‘coughing’ and ‘a body temperature above 37.8°C’ is 0.34 (95%CI 0.27-0.41) and 0.07 (95%CI 0.05-0.08),
respectively.
Conclusions: Ruling out influenza using clinical and contextual information is easier than ruling it in. Outside an
influenza epidemic the absence of cough and fever (> 37,8°C) makes influenza 14 times less likely in ILI patients.
During an epidemic the presence of ‘previous flu-like contacts’, cough, ‘expectoration on the first day of illness’ and
fever (>37,8°C) increases the likelihood for influenza threefold. The additional diagnostic value of rapid point of care
tests especially for confirming influenza still has to be established.
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Especially during an influenza pandemic prompt diagno-
sis of influenza is important for the individual patient
and society as well. Diagnosing of influenza is still
essentially based on the interpretation of symptoms and
signs, notwithstanding the growing support of point-of-
care tests.
All primary care practitioners and especially members
of influenza surveillance systems (Fluview(Ilinet), USA:
http://www.cdc.gov/flu/, Euroflu, Europe: http://www.
euroflu.org) need a performing prediction rule to diag-
nose influenza. The clinical definitions used for report-
ing cases of influenza in different surveillance systems
[1-3] vary widely, are often imprecise and have never
been evaluated [4]. Most frequently inclusion criteria for
influenza-like illness (ILI) are based on four to six of the
nine criteria (sudden onset, cough, rigors and chills,
fever, prostration and weakness, headache, myalgia,
widespread aches and pain, influenza in close contact)
of the ICHPPC-2 classification (International Classifica-
tion of Health Problems in Primary Care)[5]. A poor
relation between these criteria and laboratory confirmed
influenza cases has been reported[6,7].
It is important to distinguish between the classic influ-
enza syndrome consisting of sudden onset, fever, head-
ache, cough, sore throat, myalgia, nasal congestion,
weakness and loss of appetite[8], and those symptoms
and signs which can be used to discriminate from other
ILIs. Besides recurrent symptoms like cough and fever,
there are other symptoms like acute onset[8,9], malaise,
chills, sore throat, muscle pain and nose symptoms
[10,11], that were found in one study, but could not be
confirmed in another. Unfortunately these symptoms
are frequently seen in other respiratory infections caused
by a variety of viral and non-viral pathogens. No single
symptom is specific enough to be useful in differentiat-
ing influenza from these respiratory infections[10].
Since the development of clinical prediction rules sys-
tematically combining symptoms and other information
might be a more useful strategy[11], the goal of this
study is to formulate a prediction rule for influenza in
patients presenting with an ILI with the best diagnostic
performance in general practice based on the combina-
tion of symptoms, signs and contextual information.
Methods
Setting, design and participants
A large cross sectional study was conducted based on the
information collected during five consecutive surveillance
periods (2002-2007) by the sentinel network of general
practitioners (GPs) commissioned by the Scientific Insti-
tute of Public Health (SIPH), Brussels in Belgium http://
www.iph.fgov.be/epidemio/epien/index10.htm. Age,
gender and geographic distribution of the participating
GPs are representative for Belgium. Eligible patients were
informed about the goal of influenza surveillance, no
written informed consent was provided. The information
was handled totally anonymously. Ethics approval was
granted. Each surveillance period, i.e. from October
(week 40) until April (week 20), the sentinel GPs took
one oro- and two naso-pharyngeal swabs from some of
their patients (all ages) consulting with a new ILI charac-
terized by a broad clinical picture with sudden onset of
fever (measurement and threshold undefined), respira-
tory symptoms (like cough) and systemic symptoms (like
myalgia). At the same time they registered the corre-
sponding symptoms and signs as well as general charac-
teristics and contextual information by checking each
item if positive on a pre-printed form. Only swab
sampled records were included in this study. The swabs
were stored in a transport medium (Eagle’sm i n i m u m
essential medium, with addition of antibiotics and anti-
mycotics) before sending them by post (free of charge) to
the laboratory of virology of the SIPH National Influenza
Centre.
Test methods
The swabs were tested upon reception using a rapid
antigen diagnostic test (DirectigenFlu_A&B). The sam-
ples were then submitted to a panel of RT-PCR assays
(real time or nested polymerase chain reaction) for typ-
ing Influenza A and B, our reference test. All influenza
A positive samples were then sub typed (H1N1 and
H3N2). Laboratory personal was blinded for the clinical
information.
The index tests consisted of a combination of some of
the following symptoms or signs collected on the
pre-printed form: sudden onset, shivering, weakness,
headache, muscle pain, lack of appetite, cough, expec-
toration, nose-, eye- and ear symptoms, red throat, dys-
pnoea, rhonchi, gastro-intestinal symptoms, confusion,
dizziness, age (years), the number of illness days (from
the start of the first ILI symptoms to the day swabs
were taken), influenza vaccination, ILI contacts in the
family, school- or workplace, highest body temperature
(°C) measured before the intake of antipyretics.
Data management
In the original data file body temperature was dichoto-
mized to below (or equal to) and above 37.8°C. The
number of illness days exceeding 14 days were consid-
ered as missing.
Extra variables were introduced: ‘influenza year’, corre-
sponding to the surveillance period each year, starting in
October; ‘influenza epidemic’ corresponding to whether
or not the number of ILI consultations exceeds the
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European Influenza Surveillance Scheme for Belgium
[12]); ‘RSV (Respiratory Syncytial Virus) epidemic’,c o r -
responding to whether or not more than 100 confirmed
RSV cases per week were reported by the sentinel
laboratories in Belgium[13]. No RSV testing was per-
formed on the swabs.
Statistical methods
Positively skewed variables were log transformed. The
pattern of missing data was considered to be at random
(MAR). The variables with missing values (temperature,
age and number of illness days) were included in an
imputation model with all other symptom variables,
influenza epidemic and RSV epidemic. Besides the main
effects the interactions were also present in the imputa-
tion model, ensuring that interactions could properly be
allowed in the analysis models. We conducted 10 impu-
tations using the MCMC (Markov chain Monte Carlo)
method (= a single chain for all imputations with 200
burn-in iterations followed by 100 iterations between
successive imputations) stratified for the five influenza
years, using the multiple imputation procedure of SAS
(version 9.2).
Each imputed data set was analysed using a GEE
(Generalized Estimating Equations) model with influ-
enza positive PCR as the dependent variable and GP
code as a cluster variable (as a check on possible clus-
tering of inclusion criteria and symptom registration
within GPs). A backward regression analysis starting
from a model with all symptoms and interaction terms
(pre-planned on clinical relevance) between all symp-
toms and influenza epidemic, RSV epidemic, vaccine
use, number of illness days and age was performed.
When convergence problems occurred the responsible
variable was eliminated. After stepwise elimination of
interaction terms a forward introduction of interaction
terms with borderline p-value was executed. The final
model contained all single symptoms, signs and contex-
tual variables together with interaction terms with a
p-value less than 0.001 (to deal with multiple compari-
sons). Parameter estimates of relevant variables and
interaction terms were then averaged across data sets by
using a bootstrap technique (SAS macro)[14].
Starting from the most relevant variables in the GEE
model, we calculated the area under the Receiver Oper-
ating Characteristic (ROC) curve (AUC), sensitivity, spe-
cificity and likelihood ratios for positive (LR+) and
negative test results (LR-) for different single signs,
symptoms and context and their combinations taking
into account pre-test and post-test odds as described by
Janssens A et al[15].
To enforce the internal validity, the outcomes and
their 95% confidence interval (CI) were calculated using
a bootstrap method. The combination of symptoms,
signs and/or context with the best LR+ and LR- were
used to define clinical prediction rules taking into
account logical clinical order. Finally, sensitivity analyses
were done for the different influenza strains A and B,
for the different surveillance periods, for different age
categories and on the records with complete data.
Results
In total 138 sentinel general practitioners included and
sampled 4 597 of all eligible ILI patients (exact number
unknown) during the 5 surveillance periods (Table 1-
Figure 1). Information about the general characteristics
of the eligible non-participants and reasons for non-par-
ticipation were not registered. Most records (25.22%)
were collected in year 2006-2007. Thirteen records
missed data for all signs and symptoms, 18.7% records
missed one or more data (maximum three per record;
temperature = 14%, age = 2%, illness days = 5%).
Through imputing missing data 4584 records could be
analysed. No relevant differences were seen between the
original, the complete record and the imputed database.
In this last database the mean age was 30 (SE 0.28), the
mean number of illness days was 1.8 (SE 0.02) and the
mean number of positive symptoms was 8.6 (SE 0.04),
and 10% were vaccinated against influenza. 70% (3212/
4584) of the records were collected during an influenza
epidemic and 44% (2036/4584) during an RSV epidemic.
52.6% of the swabs were found positive for influenza
on RT-PCR, which corresponds to a pre-test odds of
1.11 (adjusted by bootstrapping to 1.01 (95%CI 0.94-
1.08)). The final GEE model contained all the variables
recorded and defined except confusion. It was elimi-
nated because of convergence problems. Only two inter-
action terms were withheld: influenza epidemic*ILI
contacts and expectoration*illness days.
During an influenza epidemic 64% (2066/3212) of the
records were positive for influenza compared with 25%
(343/1372) before or after (Figure 2). Besides influenza
epidemic other important predictors of influenza cases
were no vaccination, body temperature above 37.8°C,
cough, nose symptoms and expectoration on the first
d a yo fi l l n e s s( T a b l e2 ) .I L Ic o n t a c t sw e r em o r ep r e d i c -
tive pre/post an epidemic (ORadj 3.14 (2.23-4.05)) than
during an epidemic (ORadj 1.24 (1.03-1.44)). Age and
many symptoms such as sudden onset, shivering, weak-
ness, headache, muscle pain, lack of appetite and eye
symptoms were also no longer significant in the
adjusted full model. There was no difference between
the two groups for ear symptoms, red throat, dyspnoea,
rhonchi, gastro-intestinal problems, confusion and
dizziness.
The variables influenza epidemic, ILI contacts, cough,
expectoration, body temperature >37.8°C and the
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tion*’number of illness days’ all had a p-value < 0,0001 in
the multivariate model. Influenza epidemic, ILI contacts,
cough, ‘expectoration per illness day’, nose symptoms, lack
of appetite and ‘body temperature > 37.8°C’ are the most
performing symptoms to discriminate influenza from other
ILIs according the AUROC (Table 3). Starting with influ-
enza epidemic and stepwise adding ILI contacts, cough,
body temperature and expectoration per day (prediction
rule 1) or adding cough and body temperature (prediction
rule 2) both give a final AUC of 0.75 (0.73-0.76). Adding
more variables does not raise the AUC any further.
During an influenza epidemic variables with high sen-
sitivity such as cough (0.82 (0.81-0.84)) and body tem-
perature (0.91 (0.89-0.92)) have a poor specificity
(respectively 0.39 (0.36-0.42) and 0.19 (0.16-0.22))
(Table 4). During the pre/post epidemic period specific
variables such as ILI contact (0.82 (0.80-0.85)), ‘expec-
toration on the first day’ (0.92 (0.65-1.00) have a bad
corresponding sensitivity (0.42 (0.36-0.47) and 0.11
(0.00-0.42), respectively).
In general the LR- of the different symptoms performs
better than the LR+. The values are alike during and
pre/post an influenza epidemic, except for ILI contacts
because of the significant interaction of this variable
with influenza epidemic.
The LR+ of an influenza epidemic is 1.50 (1.43-1.57).
Prediction rule 1 then gives a cumulative LR+ of 3.35
(2.67-4.03) and an LR- of 0.26 (0.18-0.34). Prediction
rule 2 gives a cumulative LR+ of 2.26 (2.11-2.40) and an
LR- of 0.34 (0.27-0.41). Adding more information has
no additional diagnostic value.
The LR- of an influenza epidemic is 0.30 (0.26-0.33).
In this situation ‘previous ILI contacts’ is more impor-
tant and this information raises the likelihood by a fac-
tor of 2.36. For prediction rule 1 the cumulative LR+
now is 1.34 (0.97-1.72). The corresponding LR- is 0.04
(0.03-0.05). For prediction rule 2 the LR+ now is 0.46
(0.41-0.51), the LR- is 0.07 (0.05-0.08). When some
symptoms are present and others are absent the predic-
tion rules have lower LR+ and higher LR-.
There is no statistical or relevant difference in perfor-
mance of both prediction rules between influenza A and
B, nor between the surveillance periods or ages (Table
5). Pre/post an influenza epidemic no prediction rule
can help to confirm influenza in the age group <5 years
and >65 years. Ruling out influenza seems to be easier
in the younger age groups.
Table 1 General characteristics of the included subjects
All subjects
(n = 4597)
Subjects with
full records
(n = 3738)
Subjects with full and
imputed records
(n = 4584)
Patient age (n = 4510)
Median (range) 28 (0 to 99) 27 (0 to 99) 28 (0 to 99)
Mean (SE) 30.0 (0.29) 29.4 (0.32) 30.0 (0.28)
Number of subjects (%)
By influenza year
2002-2003 585 (12.73) 479 (12.81) 584 (12.74)
2003-2004 1066 (23.19) 851 (22.77) 1064 (23.21)
2004-2005 996 (21.67) 825 (22.07) 995 (21.71)
2005-2006 785 (17.08) 663 (17.74) 785 (17.12)
2006-2007 1165 (25.34) 920 (24.61) 1156 (25.22)
During an influenza epidemic 3221 (70.07) 2650 (70.89) 3212 (70.07)
With ILI-contact in family. school- or workplace 1492 (32.46) 1195 (31.97) 1490 (32.50)
Vaccinated against influenza 466 (10.14) 377 (10.09) 465 (10.14)
During an RSV epidemic 2039 (44.36) 1635 (43.74) 2036 (44.42)
Number of symptoms
Median (range) 8 (0 to 18) 9 (1 to 18) 9 (1 to 18)
Mean (SE) 8.4 (0.04) 8.6 (0.04) 8.6 (0.04)
Number of illness days
a (n = 4381)
Median (range) 1.5 (0 to 39) 1.5 (0 to 14) 2 (0 to 14)
Mean (SE) 1.76 (0.02) 1.72 (0.02) 1.77 (0.02)
Number of records per GP (n = 138) (n = 134) (n = 137)
Median (range) 10 (1 to 247) 7 (1 to 217) 10 (1 to 246)
Mean (SE) 33.5 (4.5) 27.9 (4.0) 33.5 (4.5)
SE = standard error.
aillness days above 14 days were considered as missing.
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In patients presenting with ILI in primary care ruling
out influenza is easier than confirming it. Pre/post an
i n f l u e n z ae p i d e m i ct h ea b s e n c eo fc o u g ha n df e v e r
(>37.8°C) lowers a pre-test probability of 25% to a post-
test probability of 7%. During an epidemic with a pre-
test probability of 62%, the absence of these symptoms
gives a post-test probability of 27%. To confirm influ-
enza the presence of previous ILI contacts’,c o u g h ,
‘expectoration on the first illness day’ combined with
‘fever >37.8°C’ results in a post-test probability of 79%.
Pre/post an epidemic the presence of these items gives a
post-test probability of 60%.
Our study had to deal with some limitations. Our
study was not designed to evaluate the additional value
of rapid point of care tests, which were only performed
in the virology laboratory and not at the GP practice.
Only 20,7% of the records mentioned expectoration
on the first day of illness. Normally influenza is defined
as a respiratory infection with a dry cough. So this
symptom was only helpful in a minority of cases in the
confirmation of influenza, but even when absent predic-
tion rule 1 is still quite useful with a LR+ of 2.38 during
an influenza epidemic.
Gender information is missing in our study, but until
now no difference has been described between males
and females in the symptomatology of influenza.
Sentinel GPs did not include every patient with ILI. The
choices they made and the reasons for them are unclear:
sometimes the number of swabs were restricted by the vir-
ology lab and patients could refuse to participate. There is
no reason to believe that a systematic selection bias took
place. Especially patients with higher fever are included by
t h es e n t i n e lG P sa n dt h i sm u s tb ek e p ti nm i n d ,w h e n
extrapolating our results. The youngest age group
(<5 years) is under-represented in our database. Probably
because it is not easy to take swabs from small children
and/or in Belgium parents could have chosen to go
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Figure 1 Number of influenza-like illness (ILI) per 100 consultations and number of influenza positive specimens season 2002/2003 to
season 2006/2007. Note: this figure is part of the historical graphs made by the National Influenza Centre, Virology, Brussels, Belgium
http://www.euroflu.org/html/hist_graphs.html and used here with their permission.
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Page 5 of 11directly to a paediatrician for their first consult. Especially
in this age group extra validation is required. There are a
smaller amount of samples in the older (>64 years) age
group, but this is merely due to the lower incidence of
influenza in this age group.
The advantage of our study is the large number of
records over five surveillance periods. This allows an
extensive analysis and robust results. An advanced sta-
tistical approach was adopted to deal with missing data
other than the outcome variable to correct for potential
biases or overestimation of diagnostic values and multi-
ple comparisons. We also took into account the influ-
ence of symptoms, signs or context already considered
on the diagnostic values of new items added as well as
interactions.
That expectoration is only important when occurring
during the first few days has never been considered in
other studies [Additional fil e1 ] .C a r r a te ta l [ 4 ]f o u n d
expectoration to be present more frequently among
influenza A positive patients. Loda[16], describing the
symptoms of volunteers with an influenza illness after
nasal inoculation by a wild type influenza A, found that
cough, rhonchi and expiratory fine rales were the most
frequent and persistent manifestations. Of the initial 426
cases of the 2009 pandemic influenza A (H1N1) cases
104 (24.5%) suffered from sputum production on admis-
sion in hospital[17]. This percentage is comparable with
the incidence of expectoration on the first day of illness
in influenza cases in our study (25.3%).
The number of illness days up to now has never been
tested in interaction with other variables and was sel-
dom considered as a continuous variable. Stein et al[18]
compared the performance of clinician judgement, a
rapid influenza test and the prediction rule cough and
Figure 2 Diagnostic flow-diagram pre/post and during the influenza epidemics n = 4584 (imputed data). Note: about 30% of all the ILI
patients were swabbed. No information is available about the no swabbed ILI patients. From the 4597 swabbed patients 13 records missed any
clinical information. Of the remaining 4584, 18.7% had missing values in at least one of the following items: age, number of illness days and/or
temperature, 3738 were full records.
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Page 6 of 11fever, and did not see a significant effect of the duration
of illness on the overall accuracy of the latter prediction
rule. This is confirmed by our findings. In addition, the
diagnostic value of sympto m sa n ds i g n so u t s i d ee p i -
demics is scarce in the literature. To date, the value of
information about previous contact with other ILI cases,
especially pre/post the epidemic, has never been shown.
The prevailing prediction rule has been generated from
a selected patient population that was recruited to study
the effects of neuraminidase inhibitors. The strict inclu-
sion criteria for those studies excluded many patients
that would have normally presented for evaluation of
acute respiratory symptoms in primary care[18].
During an influenza epidemic our findings about cough
and fever especially, corroborate previous findings. Boivin
et al concluded in 2000 that the combination of cough,
fever and the knowledge of an epidemic gave the best
prediction and that physicians could correctly diagnose
influenza in over 60-70% of their patients on the basis of
clinical symptoms alone[19]. The systematic review of
Call et al[10], including the large study of Monto[8],
showed that no symptom or sign had an LR+ greater
than 2 in studies that enrolled patients with disregard to
age. To rule out influenza the absence of fever (LR- 0.40;
95%CI: 0.25-0.66), cough (LR- 0.42; 0.31-0.57) or nasal
congestion (LR- 0.49; 0.42-0.59) were the only findings
that had an LR- less than 0.5.
In our study we found small, not statistically signifi-
cant, differences in diagnostic accuracy of the two predic-
tion rules according to different age-categories, and no
Table 2 Presence of context, signs and symptoms in influenza positive and negative subjects and corresponding
crude
a and adjusted odds ratios (95%CI)
b
Contexts. signs and symptoms Influenza pos
(n = 2409)
Influenza neg
(n = 2175)
Crude OR
(95%CI)
Adjusted OR
(95%CI)
Body temperature >37.8°C. No. (%) 2271 (94.3) 1902 (87.5) 2.36 (1.91 to 2.92) 2.13 (1.58 to 2.68)
c
Sudden onset. No. (%) 2154 (89.4) 1874 (86.2) 1.36 (1.14 to 1.62) 1.25 (0.99 to 1.51)
Influenza epidemic. No. (%) 2066 (85.8) 1146 (52.7) 5.41 (4.69 to 6.23) 6.28 (5.03 to 7.54)
c
Cough. No. (%) 2060 (85.5) 1425 (65.5) 3.11 (2.69 to 3.59) 2.59 (2.14 to 3.04)
c
Shivering. No. (%) 1999 (83.0) 1706 (78.4) 1.34 (1.16 to 1.55) 1.13 (0.92 to 1.33)
Weakness. No. (%) 1965 (81.6) 1691 (77.7) 1.27 (1.10 to 1.46) 1.03 (0.84 to 1.21)
Headache. No. (%) 1918 (79.6) 1590 (73.1) 1.44 (1.25 to 1.65) 1.16 (0.96 to 1.37)
Muscle pain. No. (%) 1838 (76.3) 1567 (72.0) 1.25 (1.09 to 1.43) 1.16 (0.97 to 1.36)
Nose symptoms. No. (%) 1620 (67.2) 1208 (55.5) 1.64 (1.46 to 1.85) 1.38 (1.18 to 1.58)
Red throat. No. (%) 1529 (63.5) 1333 (61.3) 1.10 (0.97 to 1.24) 0.95 (0.81 to 1.09)
Lack of appetite. No. (%) 1453 (60.3) 1130 (52.0) 1.41 (1.25 to 1.58) 1.15 (0.98 to 1.32)
RSV epidemic. No. (%) 1026 (42.6) 1010 (46.4) 0.86 (0.76 to 0.96) 1.14 (0.99 to 1.29)
ILI contacts in the family. school or workplace. No. (%) 928 (38.5) 562 (25.8) 1.80 (1.59 to 2.04) Not in model
ILI contacts pre/post an epidemic. No. (%). n = 1372 134 (39.1) 180 (17.5) 3.02 (2.31 to 3.96) 3.14 (2.23 to 4.05)
c
ILI contacts during an epidemic. No. (%)
c. n = 3212 79’4 (38.4) 382 (33.3) 1.25 (1.07 to 1.45) 1.24 (1.03 to 1.44)
Expectoration. No. (%) 661 (27.4) 456 (21.0) 1.43 (1.24 to 1.63) Not in model
Expectoration on illness day 0. No. (%). n = 117 9 (18.37) 15 (22.06) 0.80 (0.32 to 2.00) 2.24 (0.93 to 3.55)
Expectoration on illness day 1. No. (%). n = 2101 269 (25.33) 165 (15.88) 1.80 (1.45 to 2.23) 1.36 (1.06 to 1.66)
c
Expectoration on illness day 2. No. (%). n = 1676 262 (27.61) 159 (21.87) 1.35 (1.09 to 1.71) 1.00 (0.83 to 1.17)
Eye symptoms. No. (%) 659 (27.4) 481 (22.1) 1.33 (1.16 to 1.52) 1.08 (0.90 to 1.27)
Gastro-intestinal symptoms. No. (%) 368 (15.3) 374 (17.2) 0.87 (0.74 to 1.02) 0.84 (0.68 to 1.00)
Ear symptoms. No. (%) 355 (14.7) 304 (14.0) 1.06 (0.90 to 1.26) 0.88 (0.71 to 1.05)
Dyspnoe. No. (%) 236 (9.8) 186 (8.6) 1.16 (0.95 to 1.42) 1.18 (0.90 to 1.45)
Dizziness. No. (%) 233 (9.7) 177 (8.1) 1.21 (0.99 to 1.48) 1.18 (0.87 to 1.48)
Vaccination against influenza. No. (%) 198 (8.2) 267 (12.3) 0.64 (0.53 to 0.78) 0.67 (0.50 to 0.85)
Ronchi. No. (%) 166 (6.9) 136 (6.3) 1.11 (0.88 to 1.40) 0.93 (0.65 to 1.20)
Confusion. No. (%) 22 (0.9) 22 (1.0) 0.90 (0.50 to 1.63) not in model
Age difference of 10 years NA NA NA 0.97 (0.94 to 1.01)
Age. mean (SE)
c 28.90 (0.39) 31.27 (0.41) NA Not in model
Temp. mean (SE)
c 38.70 (0.01) 38.46 (0.02) NA Not in model
NA = not applicable CI = confidence interval.
aCrude Odds ratios were estimated using Chi
2.
bAdjusted odds ratios were estimated using Generalized Estimating Equations. 95%CI were calculated by bootstrap after multiple imputation.
csignificant different: p-value < 0.0001.
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Page 7 of 11Table 3 Area under the Receiver Operating Characteristic curve (95% CI) of symptoms, signs and context, single or in combination, for the diagnosis of
influenza
Symptoms. signs and context Single Combinations
Influenza epidemic 0.67 (0.65 to 0.68) Influenza epidemic + Influenza epidemic + Influenza epidemic + Influenza epidemic + Influenza epidemic + Influenza epidemic +
ILI contacts 0.56 (0.55 to 0.58) 0.68 (0.67 to 0.70) ILI contacts
a + ILI contacts + ILI contacts + 0.72 (0.71-0.74) 0.74 (0.72-0.75)
Cough 0.60 (0.59 to 0.61) 0.71 (0.70 to 0.72) 0.72 (0.71 to 0.74) Cough + Cough + Cough+ Cough+
Temp > 37.8°C 0.54 (0.53 to 0.55) 0.69 (0.68 to 0.70) 0.71 (0.69 to 0.72) 0.74 (0.72 to 0.75) Temp > 37.8°C + 0.75 (0.73-0.76) Temp+
Expectoration*illness day
b 0.56 (0.55 to 0.58) 0.70 (0.68 to 0.71) 0.70 (0.69 to 0.72) 0.73 (0.72 to 0.75) 0.75 (0.73 to 0.76) 0.72 (0.71 to 0.74) 0.75 (0.73 to 0.76)
Lack of appetite 0.54 (0.53 to 0.56) 0.69 (0.67 to 0.70) 0.70 (0.68 to 0.71) 0.73 (0.72 to 0.74) 0.74 (0.73 to 0.76) 0.72 (0.71 to 0.74) 0.75 (0.73 to 0.76)
Nose symptoms 0.56 (0.54 to 0.57) 0.69 (0.68 to 0.71) 0.70 (0.69 to 0.72) 0.73 (0.71 to 0.74) 0.74 (0.73 to 0.76) 0.70 (0.69 to 0.72) 0.75 (0.74 to 0.76)
Expectoration 0.53 (0.52 to 0.54) 0.68 (0.67 to 0.69) 0.69 (0.68 to 0.71) 0.72 (0.71 to 0.74) 0.74 (0.72 to 0.75) 0.71 (0.70 to 0.73) 0.75 (0.73 to 0.76)
Muscle pain 0.52 (0.51 to 0.53) 0.68 (0.66 to 0.69) 0.69 (0.68 to 0.71) 0.73 (0.71 to 0.74) 0.74 (0.73 to 0.76) 0.72 (0.70 to 0.73) 0.75 (0.73 to 0.76)
Flu ‘vaccine 0.52 (0.51 to 0.53) 0.67 (0.66 to 0.69) 0.69 (0.67 to 0.70) 0.73 (0.71 to 0.74) 0.74 (0.72 to 0.75) 0.72 (0.70 to 0.73) 0.75 (0.73 to 0.76)
Vertigo 0.51 (0.50 to 0.52) 0.67 (0.66 to 0.68) 0.69 (0.67 to 0.70) 0.73 (0.71 to 0.74) 0.74 (0.73 to 0.75) 0.71 (0.70 to 0.73) 0.75 (0.73 to 0.76)
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1statistically significant interaction between the individual
variables and age in the multivariate model. In the study
of Carrat[4], with a smaller sample size, this was also the
case. Govaerts et al[9] concluded that fever and cough
(and acute onset) give the best prediction in a population
of 60+ elderly during an influenza season (without pre-
selection). The different symptom patterns for different
strains, found by Carrat[4], could not be confirmed by
Monto[8,10]. We found a significantly different LR+ for
cough and fever between influenza A and B, but the clini-
cal significance of this finding is limited.
The derivation and part of the validation[20,21] have
been achieved for prediction rule 1. Prediction rule 2 has
previously been mentioned in the literature[18,19] and is
now broadly validated in our study. A large prospective
diagnostic study for influenza taking into account our
remarks might generate the broad validation and impact
analysis necessary to successfully implement our findings.
Conclusions
In patients presenting with an influenza-like illness to pri-
mary care, the asymmetric diagnostic values of combinations
of clinical and contextual information, i.e. ruling out is easier
than ruling in, have important implications for the manage-
ment of influenza. Outside an epidemic, influenza is easily
ruled out by the absence of cough and fever. Clinical and
contextual information alone might not be sufficient to rule
in influenza and to make treatment decisions, although
‘expectoration on the first day of illness’ combined with ‘pre-
vious flu-like contacts’,c o u g ha n df e v e r( > 3 7 , 8 ° C )i n c r e a s e s
the likelihood of influenza threefold during an epidemic.
The place and the additional diagnostic value of rapid point
of care tests on top of clinical and contextual information
still has to be established.
Additional material
Additional file 1: literature compilation regarding influenza
diagnosis. Additional file with information about previous published
prediction rules and diagnostic accuracy studies.
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Table 4 The sensitivity, specificity, likelihood ratios of the positive (LR+) and negative test result (LR-) of single and
combined symptoms, signs and context for the diagnosis of influenza (95%CI)
a
Symptoms. signs and context Sensitivity
(95% CI)
Specificity
(95% CI)
LR+
(95% CI)
Cumulative
b
LR+
(95% CI)
LR-
(95% CI)
Cumulative
b
LR-
(95% CI)
Influenza epidemic 0.88 (0.86 to 0.89) 0.42 (0.39 to 0.44) 1.50 (1.43 to 1.57) 0.30 (0.26 to 0.33)
During an epidemic 1.50 (1.43 to 1.57) 1.50 (1.43 to 1.57)
Prediction rule 1
+ILI contact 0.42 (0.38 to 0.46) 0.63 (0.58 to 0.68) 1.12 (1.01 to 1.24) 1.68 (1.49 to 1.88) 0.93 (0.87 to 0.98) 1.38 (1.28 to 1.49)
+cough 0.81 (0.79 to 0.84) 0.40 (0.36 to 0.44) 1.35 (1.29 to 1.40) 2.27 (2.01 to 2.53) 0.47 (0.42 to 0.52) 0.65 (0.56 to 0.74)
+expectoration day1 0.10 (0.00 to 0.40) 0.93 (0.67 to 1.00) 1.30 (1.08 to 1.53) 2.96 (2.38 to 3.54) 0.93 (0.86 to 1.00) 0.54 (0.40 to 0.68)
+body temp > 37.8°C 0.90 (0.87 to 0.92) 0.21 (0.16 to 0.26) 1.13 (1.08 to 1.19) 3.35 (2.67 to 4.03) 0.49 (0.41 to 0.58) 0.26 (0.18 to 0.34)
Prediction rule 2
+ cough 0.82 (0.81 to 0.84) 0.39 (0.36 to 0.42) 1.34 (1.29 to 1.39) 2.01 (1.90 to 2.13) 0.46 (0.41 to 0.51) 0.69 (0.60 to 0.78)
+body temp > 37.8°C 0.91 (0.89 to 0.92) 0.19 (0.16 to 0.22) 1.12 (1.08 to 1.16) 2.26 (2.11 to 2.40) 0.49 (0.40 to 0.58) 0.34 (0.27 to 0.41)
Pre/post an epidemic 0.30 (0.26 to 0.33) 0.30 (0.26 to 0.33)
Prediction rule 1
+ ILI contact 0.42 (0.36 to 0.47) 0.82 (0.80 to 0.85) 2.36 (1.93 to 2.79) 0.69 (0.54 to 0.85) 0.71 (0.64 to 0.78) 0.21 (0.18 to 0.24)
+cough 0.81 (0.78 to 0.85) 0.40 (0.34 to 0.46) 1.35 (1.28 to 1.42) 0.93 (0.73 to 1.14) 0.47 (0.41 to 0.53) 0.11 (0.09 to 0.13)
+expectoration day1 0.11 (0.00 to 0.42) 0.92 (0.65 to 1.00) 1.30 (1.08 to 1.53) 1.21 (0.89 to 1.54) 0.93 (0.85 to 1.00) 0.09 (0.06 to 0.11)
+body temp > 37.8°C 0.92 (0.88 to 0.95) 0.17 (0.11 to 0.23) 1.11 (1.05 to 1.16) 1.34 (0.97 to 1.72) 0.48 (0.39 to 0.57) 0.04 (0.03 to 0.05)
Prediction rule 2
+cough 0.78 (0.76 to 0.81) 0.45 (0.42 to 0.48) 1.42 (1.37 to 1.47) 0.42 (0.38 to 0.47) 0.49 (0.43 to 0.54) 0.14 (0.12 to 0.17)
+body temp > 37.8°C 0.93 (0.91 to 0.95) 0.15 (0.12 to 0.17) 1.09 (1.06 to 1.12) 0.46 (0.41 to 0.51) 0.48 (0.39 to 0.57) 0.07 (0.05 to 0.08)
CI = confidence interval.
aanalysis was performed on the database with full and imputed records n = 4584.
bcumulative = combined diagnostic value of all the symptoms. signs or context taken into account so far.
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